Company Profiles 2018-10-28T17:51:12+00:00

Company Profiles

SinglePoint, Inc (OTCQB: SING)- Small Cap Bulls Spotlights: SinglePoint Inc. (OTCQB: SING) this could be our next bottom bouncer. Currennt trading $0.0227 with a 52-week high of $.52.  We anticipate a big bounce back!  About SinglePoint, Inc. SinglePoint, Inc (SING) is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing… ... READ MORE
Clikia Corp. (OTC: CLKA) – The Future Of Television- The Future of Television is Here!  Huge Growth Potential In The Over-The-Top Market Estimated to Be Worth $165.13 Billion by 2025 (Source Grand View Research) !!! Currently Trading at $0.025   About Clikia TV, a Streaming Cable Television Subscription Service. ClikiaTV’s 45+ cable television channels are delivered to any device via the Clikia App (available in the iTunes Store, the Google Play Store, on Amazon and Roku, and via Google Chromecast, as well as through its inter-connected website). ClikiaTV competes in the rapidly expanding “over-the-top” marketplace, an extremely attractive and active marketplace positioned at the very center of the inevitable, unstoppable merger of… ... READ MORE
Petlife Pharmaceuticals, Inc.- PetLife Pharmaceuticals, Inc. (PetLife) has developed and is launching a new generation of HP (high potency) veterinary cancer medications and nutraceuticals, based on the same patented formula “Escozine” and production processes that have been scientifically proven as an effective treatment for cancer in humans for years. Escozine (for humans) is currently sold as either a nutraceutical or prescription drug in 40 countries including the US. Given the histology (the similarity of the cellular biology) between humans and dogs and cats and the growing body of new preclinical research (UCSD) establishing the effectiveness of Escozine for the treatment of animals, PetLife… ... READ MORE